Skip to main content
Figure 3 | Cancer Cell International

Figure 3

From: The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells

Figure 3

Effect of M344 and cisplatin treatments on the levels of BRCA1 protein expression in our panel of cell lines. Western blot analysis of BRCA1 following 24 hrs of treatment with 0.5, 1.0, or 5.0 μM M344 either alone or in combination with 2 μg/ml cisplatin. DMSO is the solvent control for the M344 treatment and 2 μg/ml cisplatin is the control for the combination treatment. The experiment was repeated with similar results. Densitometry readings are normalized to the DMSO solvent control.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us